Hemophilia and Thrombosis Treatment Center
The Hemophilia and Thrombosis Treatment Center, directed by Courtney Thornburg, M.D., is one of more than 130 centers in the country specializing in the diagnosis and treatment of individuals with bleeding disorders. It is part of a federally funded network of hemophilia treatment centers supported by the federal Maternal Child Health Bureau and Centers for Disease Control and Prevention.
Studies from the Centers for Disease Control show a 40 percent lower mortality (death) rate and a 50 percent lower hospitalization rate for males receiving care at a federally designated hemophilia treatment center. (Read more about hemophilia treatment centers.)
Our center cares for approximately 400 children in San Diego and the surrounding area with hemophilia, von Willebrand disease and platelet disorders. (For more information about hemophilia, read our frequently asked questions.)
As we believe that a family-centered, comprehensive treatment approach is essential to providing the highest quality care, we have a multidisciplinary team that includes board-certified hematology/oncology physicians, nurse practitioners, nurses, social workers, geneticists, psychologists, and physical therapists who specialize in the care of individuals with bleeding disorders.
Social workers and clinical psychologists help address patients’ unique psychosocial needs. Geneticists are available to provide genetic counseling, and physical therapists help with the management and prevention of musculoskeletal problems.
The Center is active in clinical research, participating in national outcomes studies and data collection on major complications of hemophilia, including joint disease and bloodborne viruses. We are also involved in clinical trials on the latest and most promising therapies.
Education & Advocacy
The Peckham Center is working with the local Hemophilia Foundation chapter – the Hemophilia Association of San Diego – to continue to provide patient education and advocate for patients in our community with bleeding disorders.
In the News
- Octapharma Announces Two Hemophilia A Trials to Utilize WILATE ®, Business Wire, features Courtney Thornburg, M.D. (press release)
- UC San Diego Health Joins National Clinical Trial on Hemophilia B Gene Therapy, EurekAlert, features Rady Children’s Hospital-San Diego.